Development of XCSgel-IL12 Intratumoral Immunotherapy for Triple-Negative Breast Cancer
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
North Carolina State University
Award Date
Program Name
Translational Research Grant
Program Category
Research and Equipment Support
Principal Investigator
David Zaharoff
Fiscal Year
2025
Region
Research Triangle
Project Description:
North Carolina State University received $144,000 to develop a new immunotherapy aimed at treating triple-negative breast cancer via local, direct injection into a tumor.